- Report
- February 2024
- 140 Pages
Global
From €2292EUR$2,542USD£1,965GBP
€2696EUR$2,990USD£2,312GBP
- Report
- February 2021
Global
From €2875EUR$3,188USD£2,465GBP
€3382EUR$3,750USD£2,900GBP
- Report
- July 2020
- 38 Pages
Global
From €1781EUR$1,975USD£1,527GBP
- Report
- June 2025
- 200 Pages
Japan
From €2246EUR$2,490USD£1,926GBP
- Report
- July 2024
- 140 Pages
United States
From €5366EUR$5,950USD£4,601GBP
- Report
- May 2024
- 80 Pages
United States
From €3562EUR$3,950USD£3,055GBP
- Report
- September 2023
- 111 Pages
Europe
From €5366EUR$5,950USD£4,601GBP
- Report
- April 2022
- 120 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- August 2025
- 190 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- January 2025
- 120 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- December 2024
- 125 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- June 2023
- 190 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- August 2025
- 194 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- October 2023
- 145 Pages
Global
From €2841EUR$3,150USD£2,436GBP
- Report
- August 2024
- 170 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- July 2024
- 157 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- June 2025
- 233 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- August 2025
- 187 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- August 2025
- 190 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- August 2025
- 185 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more